Type III hyperlipoproteinemia and atherosclerosis: a case report and re-evaluation
Related Experiment Videos
Insights
A patient with type III hyperlipoproteinemia (HLP) experienced sudden death. Autopsy revealed severe coronary atherosclerosis but no aortic or noncoronary artery disease, suggesting unknown factors influence HLP
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Pathology
Background:
- Type III hyperlipoproteinemia (HLP) is a rare genetic disorder characterized by elevated cholesterol and triglycerides.
- Patients with HLP have an increased risk of premature atherosclerosis.
Observation:
- A case study of a patient with type III HLP who died suddenly.
- Autopsy revealed severe atherosclerosis in native coronary arteries and saphenous vein bypass grafts.
Findings:
- Striking absence of atherosclerosis in the aorta and other noncoronary arteries.
- Coronary artery disease was the primary manifestation of atherosclerosis in this type III HLP patient.
Implications:
- Findings suggest that the distribution of atherosclerotic disease in type III HLP may be influenced by factors beyond lipid levels.
- Further research is needed to identify the specific determinants of vascular involvement in type III HLP.
- This case highlights the complex interplay between genetic predisposition and environmental factors in the pathogenesis of atherosclerosis.
Abstract:
a patient with type III hyperlipoproteinemia (HLP) who had been followed for several years at the Northwest Lipid Research Clinic died suddenly. Autopsy findings included severe atherosclerosis of the native coronaries as well as atherosclerotic involvement of saphenous vein bypass grafts. Nevertheless, there was a striking absence of atherosclerosis of the aorta or of any other noncoronary artery. These results are compared with those of previously reported cases of type III HLP, and the findings are analyzed in terms of the current concepts of the pathogenesis of type III HLP. It is suggested that there remain factors yet to be uncovered, which determine the degree and location of atherosclerotic disease involvement of the vascular tree.